FDA Device Intelligence
Home › Heraeus Medical GmbH › COPAL® exchange G

COPAL® exchange G

Heraeus Medical GmbH · Model hip S medium · UDI-DI 04260102139176

KWYKWL Prescription
10
510(k) clearances
16,531
Adverse events (49 deaths)
88
Recalls
216
Facilities

Description

COPAL® exchange G hip spacer is a temporary hip spacer implant as part of two-stage septic endoprosthesis revision based on bone cement. COPAL® exchange G hip spacer contains gentamicin. Gentamicin reduces the risk for bacterial colonization of the device and is released into the fluid surrounding the joint. COPAL® exchange G hip spacer is intended for single-use and is supplied sterile. COPAL® exchange G hip spacer is made of fully formed polymethylmethacrylate (radiopaque PMMA with gentamicin) and contains an inner stainless steel (AISI 316L) reinforcing structure. It contains the X-ray contrast medium calcium carbonate. To improve visibility in the surgical field, it has been colored with chlorophyll-copper-complex (E141).

Recalls

DateFirmReason
2025-09-23Total Joint Orthopedics, Inc.Potential packaging issue that could compromise the sterile barrier. Defect may result in loss of sterility of the device, presenting potential risk of infection if device is impla
2025-09-09BioPro, Inc.Potential packaging issue that could compromise the sterile barrier. Defect may result in loss of sterility of the device, presenting potential risk of infection if device is impla
2024-10-15Smith & Nephew, Inc.The Bipolar assembly contains an oversized Retainer Ring.
2024-04-26Exactech, Inc.The AcuMatch L-Series 22mm Inner Diameter Bipolar Hip Liner lots were packaged without the specified ethylene vinyl alcohol (EVOH) layer. Between 2004 and August 2021, our packagin
2020-02-26Biomet, Inc.Potentially insufficient cleaning process or potential inadequate process monitoring for cleaning parameters.
2020-02-26Biomet, Inc.Potentially insufficient cleaning process or potential inadequate process monitoring for cleaning parameters.
2020-02-26Biomet, Inc.Potentially insufficient cleaning process or potential inadequate process monitoring for cleaning parameters.
2020-02-26Biomet, Inc.Potentially insufficient cleaning process or potential inadequate process monitoring for cleaning parameters.
2020-02-26Biomet, Inc.Potentially insufficient cleaning process or potential inadequate process monitoring for cleaning parameters.
2020-02-26Biomet, Inc.Potentially insufficient cleaning process or potential inadequate process monitoring for cleaning parameters.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.